<SEC-DOCUMENT>0001096906-22-000245.txt : 20220202
<SEC-HEADER>0001096906-22-000245.hdr.sgml : 20220202
<ACCEPTANCE-DATETIME>20220201184431
ACCESSION NUMBER:		0001096906-22-000245
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220201
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220202
DATE AS OF CHANGE:		20220201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12575
		FILM NUMBER:		22580706

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>utmd-20220201.htm
<DESCRIPTION>UTAH MEDICAL PRODUCTS, INC. - FORM 8-K SEC FILING
<TEXT>
<XBRL>
<?xml version='1.0' encoding='us-ascii' standalone='no'?>
<html xmlns='http://www.w3.org/1999/xhtml' xmlns:xbrli='http://www.xbrl.org/2003/instance' xmlns:dei='http://xbrl.sec.gov/dei/2020-01-31' xmlns:i='http://www.xbrl.org/2003/instance' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:ix='http://www.xbrl.org/2013/inlineXBRL' xmlns:ixt='http://www.xbrl.org/inlineXBRL/transformation/2015-02-26' xmlns:ixt-sec='http://www.sec.gov/inlineXBRL/transformation/2015-08-31' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance'>
<head>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2022 [PPXK5GW761L0VFNE7HJL]. www.edgarsuite.com -->
<title>UTAH MEDICAL PRODUCTS, INC. - Form 8-K SEC filing</title>
<meta content='text/html; charset=UTF-8' http-equiv='Content-Type' />
</head>
<body>
<div style='display:none'>
<ix:header>
<ix:hidden>
<ix:nonNumeric name='dei:EntityCentralIndexKey' contextRef='D220201' id='fact1'>0000706698</ix:nonNumeric>
<ix:nonNumeric name='dei:AmendmentFlag' contextRef='D220201' id='fact2'>false</ix:nonNumeric>
</ix:hidden>
<ix:references>
<link:schemaRef xlink:arcrole='http://www.xbrl.org/2003/linkbase' xlink:href='utmd-20220201.xsd' xlink:type='simple'/>
</ix:references>
<ix:resources>
<i:context id='D220201'>
<i:entity>
<i:identifier scheme='http://www.sec.gov/CIK'>0000706698</i:identifier>
</i:entity>
<i:period>
<i:startDate>2022-02-01</i:startDate>
<i:endDate>2022-02-01</i:endDate>
</i:period>
</i:context>
</ix:resources>
</ix:header>
</div>
<div style='margin-left:72pt;width:468pt'><hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:14pt Times New Roman;margin:0;text-align:center'><b>UNITED STATES </b></p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
<p style='font:15pt Times New Roman;margin:0;text-align:center'><b>Washington, D.C. &#160;20549</b></p>
<p style='font:15pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'><b>FORM <ix:nonNumeric name='dei:DocumentType' contextRef='D220201' escape='true'>8-K</ix:nonNumeric></b></p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'><b>CURRENT REPORT</b></p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:12pt Times New Roman;margin:0;text-align:center'><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'>Date of Report (date of earliest event reported): &#160;<b><ix:nonNumeric name='dei:DocumentPeriodEndDate' contextRef='D220201' format='ixt:datemonthdayyearen'>February 1, 2022</ix:nonNumeric></b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<table style='border-collapse:collapse;width:100%'><tr><td colspan='5' valign='top' style='width:100%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:14pt'><b><ix:nonNumeric name='dei:EntityRegistrantName' contextRef='D220201' escape='true'>UTAH MEDICAL PRODUCTS, INC.</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td colspan='5' valign='top' style='width:100%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Exact name of registrant as specified in its charter)</p>
</td></tr>
<tr><td valign='top' style='width:31.56%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:2.68%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:2.68%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:31.56%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'><b><ix:nonNumeric name='dei:EntityIncorporationStateCountryCode' contextRef='D220201' format='ixt-sec:stateprovnameen'>Utah</ix:nonNumeric></b></p>
</td><td valign='top' style='width:2.68%'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:11pt'><b><ix:nonNumeric name='dei:EntityFileNumber' contextRef='D220201' escape='true'>000-12575</ix:nonNumeric></b></span></p>
</td><td valign='top' style='width:2.68%'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:11pt'><b><ix:nonNumeric name='dei:EntityTaxIdentificationNumber' contextRef='D220201' escape='true'>87-0342734</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td valign='top' style='width:31.56%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(State or other jurisdiction of</p>
</td><td valign='top' style='width:2.68%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Commission File Number)</p>
</td><td valign='top' style='width:2.68%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(IRS Employer</p>
</td></tr>
<tr><td valign='top' style='width:31.56%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>incorporation or organization)</p>
</td><td valign='top' style='width:2.68%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:2.68%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>Identification No.)</p>
</td></tr>
</table>
<p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<table style='border-collapse:collapse;width:100%'><tr><td valign='top' style='width:65.78%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b><ix:nonNumeric name='dei:EntityAddressAddressLine1' contextRef='D220201' escape='true'>7043 South 300 West</ix:nonNumeric></b></span></p>
</td><td valign='top' style='width:2.68%'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:65.78%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b><ix:nonNumeric name='dei:EntityAddressCityOrTown' contextRef='D220201' escape='true'>Midvale</ix:nonNumeric></b><b>, </b><b><ix:nonNumeric name='dei:EntityAddressStateOrProvince' contextRef='D220201' format='ixt-sec:stateprovnameen'>Utah</ix:nonNumeric></b></span></p>
</td><td valign='top' style='width:2.68%'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b><ix:nonNumeric name='dei:EntityAddressPostalZipCode' contextRef='D220201' escape='true'>84047</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td valign='top' style='width:65.78%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Address of principal executive offices)</p>
</td><td valign='top' style='width:2.68%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Zip code)</p>
</td></tr>
<tr><td valign='top' style='width:65.78%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:2.68%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:65.78%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:11pt Times New Roman;margin:0'>Registrant&#8217;s telephone number, including area code: &#160;</p>
</td><td valign='top' style='width:2.68%'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b>Phone: </b><b>(</b><b><ix:nonNumeric name='dei:CityAreaCode' contextRef='D220201' escape='true'>801</ix:nonNumeric></b><b>) </b><b><ix:nonNumeric name='dei:LocalPhoneNumber' contextRef='D220201' escape='true'>566-1200</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td valign='top' style='width:65.78%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:2.68%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:31.54%'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:100%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:12pt Times New Roman;margin:0;text-align:center'><b>n/a</b></p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:100%;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Former name or former address, if changed since last report)</p>
</td></tr>
</table>
<p style='font:11pt Times New Roman;margin:0;margin-right:72pt;text-align:justify'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<table style='border-collapse:collapse;width:100%'><tr><td valign='top' style='width:5.86%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:WrittenCommunications' contextRef='D220201' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:94.14%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>
</td></tr>
<tr><td valign='top' style='width:5.86%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:94.14%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:5.86%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:SolicitingMaterial' contextRef='D220201' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:94.14%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>
</td></tr>
<tr><td valign='top' style='width:5.86%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:94.14%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:5.86%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:PreCommencementTenderOffer' contextRef='D220201' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:94.14%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>
</td></tr>
<tr><td valign='top' style='width:5.86%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:94.14%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:5.86%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:PreCommencementIssuerTenderOffer' contextRef='D220201' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:94.14%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>
</td></tr>
<tr><td valign='top' style='width:5.86%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:94.14%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:100%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).</p>
</td></tr>
<tr><td valign='top' style='width:5.86%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:94.14%'><p style='font:10pt Times New Roman;margin:0;text-align:right'>Emerging growth company <ix:nonNumeric name='dei:EntityEmergingGrowthCompany' contextRef='D220201' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:100%'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:100%'><p style='font:10pt Times New Roman;margin:0'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&#160;&#160;]</p>
</td></tr>
</table>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><hr style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'/><p style='line-height:0;margin:0'></p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:10pt Times New Roman;margin:0'><b>ITEM 2.02&#8212;RESULTS OF OPERATIONS AND FINANCIAL CONDITION</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;margin-left:57.6pt'>Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and twelve months ended December 31, 2021 and forward-looking statements relating to 2021 and beyond as presented in a press release dated February 1, 2022. &#160;The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, as amended, except to the extent that such information is superseded by information as of a subsequent date that is included in or incorporated by reference into such registration statement. The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'><b>ITEM 9.01&#8212;FINANCIAL STATEMENTS AND EXHIBITS</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>The following is filed as an exhibit to this report: &#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<table style='border-collapse:collapse;width:100%'><tr><td valign='top' style='width:12.56%;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><p style='font:10pt Times New Roman;margin:0;text-align:center'><b>Exhibit</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>Number*</b></p>
</td><td valign='top' style='width:2.62%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:69.22%;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>Title of Document</b></p>
</td><td valign='top' style='width:2.62%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.98%;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>Location</b></p>
</td></tr>
<tr><td valign='top' style='background-color:#CCEEFF;width:12.56%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><b>Item 99.1</b></p>
</td><td valign='top' style='background-color:#CCEEFF;width:2.62%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='background-color:#CCEEFF;width:69.22%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><span style='color:#0000FF;border-bottom:1px solid #0000FF'><a href='utah_ex99z1.htm' style='text-decoration:none'>Financial information for Utah Medical Products, Inc. for the three and twelve months ended December 31, 2021 and forward-looking statements relating to 2021 and beyond as presented in a press release dated February 1, 2022.</a></span></p>
</td><td valign='top' style='background-color:#CCEEFF;width:2.62%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='background-color:#CCEEFF;width:12.98%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:12.56%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:2.62%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:69.22%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:2.62%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:12.98%;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>This filing</p>
</td></tr>
</table>
<p style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:18pt;text-align:justify'>_______________________________________</p>
<p style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt;margin-left:18pt;text-align:justify'><kbd style='position:absolute;font:10pt Times New Roman;margin-left:-18pt'>*</kbd>All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. &#160;</p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><hr style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'/><p style='line-height:0;margin:0'></p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:10pt Times New Roman;margin:0;text-align:center'><b>SIGNATURES</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<table style='border-collapse:collapse;width:100%'><tr><td valign='top' style='width:48.84%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:51.16%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><b>UTAH MEDICAL PRODUCTS, INC.</b></p>
</td></tr>
<tr><td valign='top' style='width:48.84%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:51.16%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:48.84%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:51.16%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:48.84%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:51.16%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:48.84%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Dated: &#160;February 1, 2022</p>
</td><td valign='top' style='width:5.62%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>By:</p>
</td><td valign='top' style='width:45.54%;border-bottom:0.5pt solid #000000'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>/s/ Kevin L. Cornwell</p>
</td></tr>
<tr><td valign='top' style='width:48.84%'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:5.62%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:45.54%;border-top:0.5pt solid #000000'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Kevin L. Cornwell, Chief Executive Officer</p>
</td></tr>
</table>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/></div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>utah_ex99z1.htm
<DESCRIPTION>PRESS RELEASE ISSUED FEBRUARY 1, 2022
<TEXT>
<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2022 [PPXK5GW761L0VFNE7HJL]. www.edgarsuite.com -->
<HEAD>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'><B>EXHIBIT 99.1 </B></P>
<P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'><B>UTMD Reports Audited Year 2021 and Fourth Quarter Financial Performance</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:50%><P style='font:10pt Times New Roman;margin:0'>Contact: Crystal Rios (801) 566-1200</P>
</TD><TD valign=top style=width:50%><P align=right style='font:10pt Times New Roman;margin:0'>February 1, 2022</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Salt Lake City, Utah &#8211;&nbsp;The fourth calendar quarter (4Q) of 2021 financial results demonstrate Utah Medical Products, Inc.&#8217;s (Nasdaq: UTMD&#8217;s) continuing performance improvement despite many challenges related to the corona virus pandemic including on-again/off-again restrictions on so-called nonessential medical procedures, supply chain disruption, high inflation on raw materials, freight and labor costs as well as a continued shortage of labor and higher employee turnover. Because of UTMD&#8217;s unusual dip in 2020 financial performance, UTMD management continues to report quarterly income statement results compared to the same periods not only for 2021 compared to 2020, but also for 2021 compared to the pre-pandemic year of 2019. The Company exceeded its stated objective early in 2021 to try to fully recover back to its 2019 financial performance. Please see the income statements for all three years on the last page of this report. </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; &#163;&nbsp;or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and &#8364;&nbsp;or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted. &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Overview of Results</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>The following summary comparison of 4Q and calendar year 2021 income statement measures with the same periods of 2020 demonstrates a remarkable recovery:</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style=width:46.64%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'><FONT style='border-bottom:1px solid #000000'>2021 to <B>2020</B> Comparison</FONT></P>
</TD><TD valign=bottom style=width:27.48%><P align=center style='font:10pt Times New Roman;margin:0'>4Q<BR><FONT style='border-bottom:1px solid #000000'>(October&#8211;December)</FONT></P>
</TD><TD valign=bottom style=width:25.88%><P align=center style='font:10pt Times New Roman;margin:0'>Year<BR><FONT style='border-bottom:1px solid #000000'>(January-December)</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:46.64%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Revenues (Sales):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:27.48%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;&nbsp;&nbsp;&nbsp;8%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25.88%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;16%</P>
</TD></TR>
<TR><TD valign=top style=width:46.64%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Gross Profit (GP):</P>
</TD><TD valign=top style=width:27.48%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;&nbsp;12%</P>
</TD><TD valign=top style=width:25.88%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;21%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:46.64%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Operating Income (OI):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:27.48%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;&nbsp;20%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25.88%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;38%</P>
</TD></TR>
<TR><TD valign=top style=width:46.64%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Income Before Tax (EBT):</P>
</TD><TD valign=top style=width:27.48%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;&nbsp;21%</P>
</TD><TD valign=top style=width:25.88%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;38%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:46.64%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Net Income (NI):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:27.48%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;&nbsp;21%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25.88%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;37%</P>
</TD></TR>
<TR><TD valign=top style=width:46.64%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Earnings Per Share (EPS):</P>
</TD><TD valign=top style=width:27.48%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;&nbsp;21%</P>
</TD><TD valign=top style=width:25.88%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>+ &nbsp;&nbsp;37%</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>As longer-term UTMD stockholders appreciate, the above increases resulted from comparing 2021 financial results with a depressed 2020 year in which so-called &#8220;nonessential&#8221; medical procedures using UTMD&#8217;s devices were often restricted by government fiat. Perhaps the following comparison of 4Q and year 2021 with 4Q and year 2019, prior to the pandemic, might be more meaningful:</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style=width:45.76%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'><FONT style='border-bottom:1px solid #000000'>2021 to <B>2020</B> Comparison</FONT></P>
</TD><TD valign=bottom style=width:30.12%><P align=center style='font:10pt Times New Roman;margin:0'>4Q<BR><FONT style='border-bottom:1px solid #000000'>(October&#8211;December)</FONT></P>
</TD><TD valign=bottom style=width:24.1%><P align=center style='font:10pt Times New Roman;margin:0'>Year<BR><FONT style='border-bottom:1px solid #000000'>(January-December)</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:45.76%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Revenues (Sales):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:30.12%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;&nbsp;&nbsp;&nbsp;9%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:24.1%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;&nbsp;&nbsp;5%</P>
</TD></TR>
<TR><TD valign=top style=width:45.76%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Gross Profit (GP):</P>
</TD><TD valign=top style=width:30.12%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;&nbsp;&nbsp;&nbsp;4%</P>
</TD><TD valign=top style=width:24.1%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;&nbsp;&nbsp;5%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:45.76%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Operating Income (OI):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:30.12%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;&nbsp;10%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:24.1%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;&nbsp;&nbsp;7%</P>
</TD></TR>
<TR><TD valign=top style=width:45.76%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Income Before Tax (EBT):</P>
</TD><TD valign=top style=width:30.12%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;&nbsp;&nbsp;&nbsp;9%</P>
</TD><TD valign=top style=width:24.1%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;&nbsp;&nbsp;7%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:45.76%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Net Income (NI) per US GAAP:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:30.12%><P align=center style='font:10pt Times New Roman;margin:0'>(5%)</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:24.1%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ &nbsp;&nbsp;&nbsp;&nbsp;- %</P>
</TD></TR>
<TR><TD valign=top style=width:45.76%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Earnings Per Share (EPS) US GAAP:</P>
</TD><TD valign=top style=width:30.12%><P align=center style='font:10pt Times New Roman;margin:0'>(3%)</P>
</TD><TD valign=top style=width:24.1%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>+ &nbsp;&nbsp;&nbsp;&nbsp;3%</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>The above changes in NI and EPS according to U.S. Generally Accepted Accounting Principles (US GAAP) reflect a favorable adjustment to UTMD&#8217;s long term deferred tax liability (DTL) in 4Q 2019 (and therefore a reduction in income tax provision) and unfavorable adjustments in both the years of 2020 and 2021. &nbsp;In 2019, the UK lowered its corporate income tax rate for future years, and then in 2020 and in 2021 effectively raised it again. The DTL decrease in 2019 and increases in 2020 and 2021 were on the balance of Femcare identifiable intangible assets (IIA) which would be amortized through 1Q 2026. As stockholders may remember, the DTL was initiated as of the 2011 acquisition of Femcare because the expense from amortizing Femcare IIA, most of which is occurring over a fifteen year time span from the acquisition date, is not tax-deductible in the UK. According to US GAAP, the future income tax impact of a change in DTL must be recognized in the tax provision of the calendar quarter in which a tax law change is enacted. In 4Q 2019, a favorable $316 reduction in the income tax provision was recognized per US GAAP. &nbsp;In 2Q 2020, a $225 increase in deferred UK taxes over the next six years occurred because the UK decided to not </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>reduce its corporate income tax rate from 19% to 17% beginning in 2Q 2020, as was previously enacted in 2019. In 2Q 2021, another $390 increase in DTL over the remaining five years occurred because in June 2021, UK parliament ratified the Finance Minister&#8217;s plan to increase the UK corporate income tax rate from 19% to 25% beginning on April 1, 2023, which affects the deferred taxes for IIA to be amortized after April 1, 2023 until fully amortized as of 1Q 2026.</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:6pt;margin-right:-6.5pt'>UTMD management believes that the presentation of results excluding the DTL adjustments to its 2019, 2020 and 2021 income tax provisions provide meaningful supplemental information to both management and investors that is more clearly indicative of UTMD&#8217;s operating results. The non-US GAAP exclusions only affect Net Income and Earnings Per Share.</P>
<P style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>Excluding the 4Q 2019 DTL decrease and the 2Q 2020 and 2Q 2021 DTL increases which resulted in a &#8220;one-time&#8221; tax provision decrease in 2019 and increases in 2020 and 2021 due to the UK corporate income tax rate changes, the resulting comparison of non-US GAAP NI and EPS changes follow: </P>
<P style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:43.26%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0'>4Q 2021 to 4Q 2020</P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0'>4Q 2021 to 4Q 2019</P>
</TD></TR>
<TR><TD valign=top style=width:43.26%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>(October-December)</FONT></P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>(October-December)</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:43.26%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>NI (non-US GAAP):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 21%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>9%</P>
</TD></TR>
<TR><TD valign=top style=width:43.26%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>EPS (non-US GAAP):</P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>+ 21%</P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>12%</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:43.26%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0'>Year 2021 to Year 2020</P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0'>Year 2021 to Year 2019</P>
</TD></TR>
<TR><TD valign=top style=width:43.26%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>(January-December)</FONT></P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>(January-December)</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:43.26%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>NI (non-US GAAP):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 38%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>7%</P>
</TD></TR>
<TR><TD valign=top style=width:43.26%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>EPS (non-US GAAP):</P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>+ 38%</P>
</TD><TD valign=top style=width:28.36%><P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.5pt'>10%</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>In other words, excluding booking the income tax provision adjustments which resulted from DTL changes in all three years, the comparison of improvements in Net Income and EPS were similar to the improvements in income statement measures above the Net Income line. &nbsp;</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Consolidated sales in all product categories were up for the year 2021 compared to 2020. Sales invoiced in foreign currencies, which represented 27% of total consolidated sales (when expressed in USD) during 2021, were helped by a weaker USD. &nbsp;Consolidated USD sales in 2021 were 1.3% higher to that which would have resulted using the same foreign currency exchange (FX) rates as in the prior year&#8217;s same periods (&#8220;constant currency sales&#8221;).</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Profit margins in 4Q and year 2021 compared to 4Q and year 2020 follow:</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:46.22%><P style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:13.44%><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>4Q 2021 </P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'><FONT style='border-bottom:1px solid #000000'>(Oct &#8211;&nbsp;Dec)</FONT></P>
</TD><TD valign=top style='width:14.34%;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'>4Q 2020</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'><FONT style='border-bottom:1px solid #000000'>(Oct-Dec)</FONT></P>
</TD><TD valign=top style='width:14.18%;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'>2021</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'><FONT style='border-bottom:1px solid #000000'>(Jan&#8211;Dec)</FONT></P>
</TD><TD valign=top style=width:11.82%><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'>2020</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.5pt'><FONT style='border-bottom:1px solid #000000'>(Jan&#8211;Dec)</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:46.22%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Gross Profit Margin (GP/ sales):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.44%><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>62.8%</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:14.34%;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>60.5% </P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:14.18%;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>63.0%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.82%><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>60.6%</P>
</TD></TR>
<TR><TD valign=top style=width:46.22%><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Operating Income Margin (OI/ sales):</P>
</TD><TD valign=top style=width:13.44%><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>39.7%</P>
</TD><TD valign=top style='width:14.34%;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>35.6%</P>
</TD><TD valign=top style='width:14.18%;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>38.5%</P>
</TD><TD valign=top style=width:11.82%><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>32.5%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:46.22%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'>Net Income Margin &nbsp;(US GAAP)</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.44%;border-bottom:0.75pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>32.0%</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:14.34%;border-bottom:0.75pt solid #000000;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>28.4%</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:14.18%;border-left:0.5pt solid #000000;border-bottom:0.75pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>30.1%</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.82%;border-bottom:0.75pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'>25.6%</P>
</TD></TR>
<TR><TD valign=top style='width:46.22%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'><I>Net Income Margin (Non-US GAAP, B4 DTL Adj):</I></P>
</TD><TD valign=top style='width:13.44%;border-top:0.75pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'><I>32.0% </I></P>
</TD><TD valign=top style='width:14.34%;border-top:0.75pt solid #000000;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'><I>28.4%</I></P>
</TD><TD valign=top style='width:14.18%;border-top:0.75pt solid #000000;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'><I>30.9%</I></P>
</TD><TD valign=top style='width:11.82%;border-top:0.75pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:7.1pt;margin-right:-6.3pt'><I>26.1%</I></P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:0pt'>Notes:</KBD><KBD style=margin-left:36pt></KBD>1) There were no DTL adjustments in 4Q 2021 or in 4Q 2020. &nbsp;</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt;text-indent:36pt'>2) The Net Income Margin is NI, after subtracting a provision for taxes, divided by sales.</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>In 2020, because the Company did not make drastic cuts to its operating overheads to try to match the lower sales activity, profit margins were lower relative to UTMD&#8217;s performance in prior years, but still remained very solid in regard to UTMD&#8217;s ability to remain viable during the pandemic. The decision to not cut back was based on management&#8217;s belief that most overhead expenses represented critical resources needed to support the business as it was expected to recover, together with the comfort of UTMD&#8217;s cash reserves. &nbsp;Profit margins in 2021 have returned to levels more consistent with longer term management expectations. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>UTMD&#8217;s December 31, 2021 Balance Sheet, in the continued absence of debt, continued to strengthen, which allowed the payment of a $2.00/share special dividend to stockholders in December which amounted to $7,309 in total. This payment was in addition to the regular $0.285/share dividend declared after 3Q 2021 ($1,040 total) and also paid during 4Q 2021 in October, and in lieu of UTMD&#8217;s regular $0.285/share 4Q dividend which would normally have been paid in January 2022. The early special dividend payment was intended to mitigate a negative tax impact on stockholders of a possible income tax rate increase on dividends in 2022. After the $8,349 payment of dividends during 4Q 2021, ending Cash and Investments were $60.9 million on December 31, 2021 compared to </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>$64.3 million on September 30, 2021 and $51.6 million on December 31, 2020. Even after paying a total of $11.5 million in cash dividends to stockholders during 2021, UTMD&#8217;s cash balance increased $9.4 million during 2021, or about $2.57/ currently outstanding share. Stockholders&#8217; Equity (SE) increased $4.3 million as of December 31, 2021 from December 31, 2020 despite the fact that dividends reduce SE. &nbsp;&nbsp;</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Foreign currency exchange (FX) rates for Balance Sheet purposes are the applicable rates at the end of each reporting period. The FX rates from the applicable foreign currency to USD for assets and liabilities at the end of calendar year 2021 compared to the end of 2020 and the end of 3Q 2021 follow:</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:20.04%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:13.46%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>12-31-21</FONT></P>
</TD><TD valign=top style=width:14.9%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>12-31-20</FONT></P>
</TD><TD valign=top style='width:17.2%;border-right:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Change</FONT></P>
</TD><TD valign=top style='width:14.9%;border-left:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>9-30-21</FONT></P>
</TD><TD valign=top style=width:19.5%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Change</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:20.04%><P style='font:10pt Times New Roman;margin:0'>GBP</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.46%><P align=center style='font:10pt Times New Roman;margin:0'>1.35358</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.9%><P align=center style='font:10pt Times New Roman;margin:0'>1.36631</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.2%;border-right:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>(0.9%)</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:14.9%;border-left:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>1.34676</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:19.5%><P align=center style='font:10pt Times New Roman;margin:0'>0.5%</P>
</TD></TR>
<TR><TD valign=top style=width:20.04%><P style='font:10pt Times New Roman;margin:0'>EUR</P>
</TD><TD valign=top style=width:13.46%><P align=center style='font:10pt Times New Roman;margin:0'>1.13765</P>
</TD><TD valign=top style=width:14.9%><P align=center style='font:10pt Times New Roman;margin:0'>1.22281</P>
</TD><TD valign=top style='width:17.2%;border-right:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>(7.0%)</P>
</TD><TD valign=top style='width:14.9%;border-left:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>1.15770</P>
</TD><TD valign=top style=width:19.5%><P align=center style='font:10pt Times New Roman;margin:0'>(1.7%)</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:20.04%><P style='font:10pt Times New Roman;margin:0'>AUD</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.46%><P align=center style='font:10pt Times New Roman;margin:0'>0.72678</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.9%><P align=center style='font:10pt Times New Roman;margin:0'>0.77079</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.2%;border-right:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>(5.7%)</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:14.9%;border-left:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>0.72284</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:19.5%><P align=center style='font:10pt Times New Roman;margin:0'>0.5%</P>
</TD></TR>
<TR><TD valign=top style=width:20.04%><P style='font:10pt Times New Roman;margin:0'>CAD</P>
</TD><TD valign=top style=width:13.46%><P align=center style='font:10pt Times New Roman;margin:0'>0.79016</P>
</TD><TD valign=top style=width:14.9%><P align=center style='font:10pt Times New Roman;margin:0'>0.78406</P>
</TD><TD valign=top style='width:17.2%;border-right:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>0.8%</P>
</TD><TD valign=top style='width:14.9%;border-left:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>0.78908</P>
</TD><TD valign=top style=width:19.5%><P align=center style='font:10pt Times New Roman;margin:0'>0.1%</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Revenues (sales)</FONT> - <FONT style='border-bottom:1px solid #000000'>4Q 2021</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Total consolidated 4Q 2021 UTMD worldwide (WW) sales were $903 (+7.5%) higher than in 4Q 2020. Constant currency sales were $953 (+7.9%) higher. U.S. domestic sales were 16% higher and outside the U.S. (OUS) sales were 5% lower. In contrast to the earlier three quarters of the year, a stronger USD in 4Q 2021 compared to 4Q 2020 converting foreign currency sales reduced 4Q 2021 OUS sales by 1%.</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Domestic U.S. sales in 4Q 2021 were $8,105 compared to $6,960 in 4Q 2020. &nbsp;Domestic sales are invoiced in USD and are not subject to FX rate fluctuations. The components of domestic sales include 1) &#8220;direct other device sales&#8221; of UTMD&#8217;s medical devices to user facilities (and med/surg stocking distributors for hospitals), excluding Filshie device sales, 2) &#8220;OEM sales&#8221; of components and other products manufactured by UTMD for other medical device and non-medical device companies, and 3) &#8220;direct Filshie device sales&#8221;. UTMD separates Filshie device sales from other medical device sales direct to medical facilities because of their significance, and the acquisition history. Direct other than Filshie device sales, representing 51% of total domestic sales, were $703 (+21%) higher in 4Q 2021 than in 4Q 2020. The increase may have been due in part from medical facilities overstocking medical devices as a hedge against possible supply interruptions. OEM sales, representing 31% of total domestic sales, were $719 (+40%) higher. Direct Filshie device sales, representing 18% of total domestic sales, were $278 (16%) lower in 4Q 2021 compared to 4Q 2020. &nbsp;In addition to clip implantations considered as &#8220;non-essential&#8221; by some during the pandemic, there is a recent medical trend post C-section to perform a salpingectomy/oophorectomy (removal of Fallopian tubes and/or ovaries) instead of tubal ligation.</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>OUS sales in 4Q 2021 were $4,809 compared to $5,050 in 4Q 2020. As expected, an extra one-time $478 shipment for DPT kits in 4Q 2020 requested by UTMD&#8217;s China distributor, representing 9% of OUS sales in 4Q 2020, did not repeat in 4Q 2021. Disregarding the one-time China order in 4Q 2020 and the negative FX rate impact, OUS sales in 4Q 2021 were up 6% compared to 4Q 2020. This is evidence that results for any given three month period in comparison with a previous three month period may not be indicative of comparative results for the year as a whole. </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>For clarity, 4Q 2021 USD-denominated OUS sales compared to 4Q 2020 OUS sales were lowered as a result of a stronger USD relative to the EUR which reduced OUS net sales that were invoiced in GBP, EUR, AUD and CAD foreign currencies (in constant currency terms) by $49. &nbsp;&#8220;Constant currency&#8221; sales means exchanging foreign currency sales into USD-denominated sales at the same FX rate as was in the previous period of time being compared. FX rates for income statement purposes are transaction-weighted averages. The average FX rates from the applicable foreign currency to USD during 4Q 2021 and 4Q 2020 for revenue purposes follow:</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:42.3%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2021</FONT></P>
</TD><TD valign=top style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2020</FONT></P>
</TD><TD valign=top style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Change</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:42.3%><P style='font:10pt Times New Roman;margin:0'>GBP</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>1.3482</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>1.3196</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;2.2%</P>
</TD></TR>
<TR><TD valign=top style=width:42.3%><P style='font:10pt Times New Roman;margin:0'>EUR</P>
</TD><TD valign=top style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>1.1494</P>
</TD><TD valign=top style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>1.1924</P>
</TD><TD valign=top style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>(3.6%)</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:42.3%><P style='font:10pt Times New Roman;margin:0'>AUD</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>0.7306</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>0.7294</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;0.2%</P>
</TD></TR>
<TR><TD valign=top style=width:42.3%><P style='font:10pt Times New Roman;margin:0'>CAD</P>
</TD><TD valign=top style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>0.7946</P>
</TD><TD valign=top style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>0.7670</P>
</TD><TD valign=top style=width:19.24%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;3.6%</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>The portion of OUS sales invoiced in foreign currencies in USD terms were 26% of total consolidated 4Q 2021 sales compared to 23% in 4Q 2020.</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>OUS sales invoiced in foreign currencies are due to direct end-user sales in Ireland, the UK, France, Canada, Australia and New Zealand, and to shipments to OUS distributors of products manufactured by UTMD subsidiaries in Ireland and the UK. &nbsp;In USD terms, export sales to OUS distributors from Ireland represented 69% of total OUS distributor sales. Export sales from the U.S. to OUS distributors are invoiced in USD. &nbsp;Sales to OUS distributors were 5% lower in 4Q 2021 than in 4Q 2020 due to the one-time shipment in 4Q 2020 to China from the U.S. Direct to end-user OUS 4Q 2021 sales in USD terms were 11% higher in Ireland, 29% lower in Canada, 2% higher in France and 3% higher in the UK than in 4Q 2020. &nbsp;Direct to end-user sales in Australia, which included New Zealand in 4Q 2021 but not in 4Q 2020, were 1% lower. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'><FONT style='border-bottom:1px solid #000000'>Sales</FONT> -<FONT style='border-bottom:1px solid #000000'>2021 Year</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Total consolidated 2021 UTMD worldwide (WW) sales were $6,876 (+16.3%) higher than in 2020. Constant currency sales were $6,256 (+14.8%) higher than in 2020. U.S. domestic sales were 19% higher and OUS sales were 13% higher. Without the help of a generally weaker USD in converting foreign currency sales, OUS sales were 9% higher. </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Domestic U.S. sales in 2021 were $30,659 compared to $25,866 in 2020. &nbsp;Direct device sales other than Filshie, representing 49% of total domestic sales, were $1,932 (+15%) higher in 2021 than in 2020. OEM sales, representing 31% of total domestic sales, were $3,069 (+47%) higher. Direct Filshie device sales, representing 20% of total domestic sales, were $209 (3%) lower in 2021 compared to 2020. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>OUS sales in 2021 were 13% higher at $18,395 compared to $16,312 in 2020. The increase in USD-denominated OUS sales was enhanced as a result of a generally weaker USD which added $619 to OUS sales that were invoiced in GBP, EUR, AUD and CAD foreign currencies (in constant currency terms). &nbsp;FX rates for income statement purposes are transaction-weighted averages. The weighted-average FX rates from the applicable foreign currency to USD during 2021 and 2020 for revenue purposes follow:</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:25%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2021</FONT></P>
</TD><TD valign=top style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2020</FONT></P>
</TD><TD valign=top style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Change</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:25%><P style='font:10pt Times New Roman;margin:0'>GBP</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>1.3760</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>1.2908</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;6.6%</P>
</TD></TR>
<TR><TD valign=top style=width:25%><P style='font:10pt Times New Roman;margin:0'>EUR</P>
</TD><TD valign=top style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>1.1828</P>
</TD><TD valign=top style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>1.1461</P>
</TD><TD valign=top style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;3.2%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:25%><P style='font:10pt Times New Roman;margin:0'>AUD</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>0.7514</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>0.6921</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;8.6%</P>
</TD></TR>
<TR><TD valign=top style=width:25%><P style='font:10pt Times New Roman;margin:0'>CAD</P>
</TD><TD valign=top style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>0.7977</P>
</TD><TD valign=top style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>0.7510</P>
</TD><TD valign=top style=width:25%><P align=center style='font:10pt Times New Roman;margin:0'>+ &nbsp;6.2%</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>The weighted-average favorable impact on 2021 foreign currency OUS sales was 4.9%, increasing reported USD sales by $619 relative to the same foreign currency sales in 2020. &nbsp;In constant currency terms, OUS sales in 2021 were 9.0% higher than in 2020. The portion of OUS sales invoiced in foreign currencies in USD terms was 27% of total consolidated 2021 sales compared to 22% in 2020. Direct to end-user OUS 2021 sales in USD terms were 18% higher in Ireland, 7% lower in Canada, 14% higher in France and 18% higher in the UK. Direct to end-user sales in Australia, which included New Zealand in 2021 but not in 2020, were 20% higher. Sales to OUS distributors were 13% higher in 2021 than in 2020. </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Gross Profit (GP)</FONT> </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>GP results from subtracting the costs of manufacturing, quality assurance and receiving materials from suppliers. UTMD&#8217;s GP was $847 (+11.7%) higher in 4Q 2021 than in 4Q 2020, and $5,369 (+21.0%) higher in calendar year 2021 than in 2020. &nbsp;The primary contribution to an expanded GP Margin (GPM) was much greater dilution of fixed manufacturing overhead costs by higher sales in both 4Q 2021 and year 2021. The greater percentage increase in GP than in sales is due to the ability to leverage fixed costs. Incremental direct labor costs increased as a result of inflationary pressure on wages and competition for a limited number of people currently seeking work. During 4Q 2021, UTMD continued to experience double-digit percentage cost increases in a number of raw materials, as well as in the freight cost to receive the materials. The growing administrative burden of compliance with regulatory requirements, particularly OUS, continues to pressure UTMD&#8217;s GPM. To offset continuing significant changes in manufacturing costs, UTMD increased prices for most of its devices in 4Q 2021 by about 6.5%, and reduced the duration of fixed prices to three to six months from a previous norm of one year. Managing variable manufacturing costs will continue to be a significant challenge in 2022. &nbsp;</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Operating Income (OI)</FONT> </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>OI results from subtracting Operating Expenses (OE) from GP. After subtracting OE from substantially higher 4Q and year 2021 GP, OI in 4Q 2021 was $5,129 compared to $4,280 in 4Q 2020, an increase of 19.8%; and was $18,880 for the year 2021 compared to $13,708 in 2020, an increase of 37.7%. USD OE were about the same in 4Q 2021 as in 4Q 2020, but slightly higher for the year 2021 than in 2020 as a result of a weaker USD during the first nine months of the year, as a comparison of the two tables below demonstrates. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>OE are comprised of Sales and Marketing (S&amp;M) expenses, General and Administrative (G&amp;A) expenses and Product Development (R&amp;D) expenses. The following table summarizes OE in 4Q and year 2021 compared to the same periods in 2020 by OE category:</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style=width:12.62%><P style='font:10pt Times New Roman;margin:0'>OE <BR><FONT style='border-bottom:1px solid #000000'>Category</FONT></P>
</TD><TD valign=bottom style=width:11.44%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2021</FONT></P>
</TD><TD valign=bottom style='width:9.28%;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>% of<BR><FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:11.12%;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2020</FONT></P>
</TD><TD valign=bottom style='width:11.1%;border-right:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>% of <BR><FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:11.12%;border-left:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> 2021</FONT></P>
</TD><TD valign=bottom style='width:11.1%;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>% of <BR><FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:11.12%;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> 2020</FONT></P>
</TD><TD valign=bottom style=width:11.08%><P align=center style='font:10pt Times New Roman;margin:0'>% of <BR><FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:12.62%><P style='font:10pt Times New Roman;margin:0'>S&amp;M:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.44%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>343</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:9.28%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:36pt'>2.7</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.12%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>359</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.1%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>3.0</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.12%;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>1,414</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.1%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>2.9</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.12%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>1,554</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.08%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>3.7</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:12.62%><P style='font:10pt Times New Roman;margin:0'>G&amp;A:</P>
</TD><TD valign=top style=width:11.44%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>2,499</KBD>&nbsp;</P>
</TD><TD valign=top style='width:9.28%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:36pt'>19.3</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.12%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>2,515</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.1%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>21.0</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.12%;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>10,097</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.1%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>20.6</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.12%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>9,800</KBD>&nbsp;</P>
</TD><TD valign=top style=width:11.08%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>23.2</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:12.62%><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>R&amp;D:</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.44%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>141</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:9.28%;border-bottom:0.75pt solid #000000;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:36pt'>1.1</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.12%;border-left:0.5pt solid #000000;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>111</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.1%;border-bottom:0.75pt solid #000000;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>0.9</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.12%;border-left:1.5pt solid #000000;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>526</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.1%;border-bottom:0.75pt solid #000000;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>1.1</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.12%;border-left:0.5pt solid #000000;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>486</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.08%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>1.2</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:12.62%><P style='font:10pt Times New Roman;margin:0'>Total OE:</P>
</TD><TD valign=top style='width:11.44%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>2,983</KBD>&nbsp;</P>
</TD><TD valign=top style='width:9.28%;border-top:0.75pt solid #000000;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:36pt'>23.1</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.12%;border-top:0.75pt solid #000000;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>2,985</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.1%;border-top:0.75pt solid #000000;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>24.9</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.12%;border-top:0.75pt solid #000000;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>12,037</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.1%;border-top:0.75pt solid #000000;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>24.6</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.12%;border-top:0.75pt solid #000000;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>11,840</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.08%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>28.1</KBD>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>A weaker USD helped increase consolidated USD sales in 2021, but it also helped increase the USD-denominated OE of UTMD&#8217;s foreign subsidiaries by $13 in 4Q 2021 and $229 in year 2021. The following table summarizes &#8220;constant currency&#8221; OE in 4Q and year 2021 compared to the same periods in 2020 by OE category:</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style=width:12.68%><P style='font:10pt Times New Roman;margin:0'>OE <BR><FONT style='border-bottom:1px solid #000000'>Category</FONT></P>
</TD><TD valign=bottom style=width:11.46%><P align=center style='font:10pt Times New Roman;margin:0'>4Q 2021 <FONT style='border-bottom:1px solid #000000'>const FX</FONT></P>
</TD><TD valign=bottom style='width:9.26%;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:11.14%;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2020</FONT></P>
</TD><TD valign=bottom style='width:11.06%;border-right:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:11.14%;border-left:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'> 2021 <BR><FONT style='border-bottom:1px solid #000000'>const FX</FONT></P>
</TD><TD valign=bottom style='width:11.06%;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:11.14%;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'> 2020</FONT></P>
</TD><TD valign=bottom style=width:11.06%><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:12.68%><P style='font:10pt Times New Roman;margin:0'>S&amp;M:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.46%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>343</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:9.26%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.14%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>359</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.06%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.14%;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>1,393</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.06%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.14%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>1,554</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.06%><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:12.68%><P style='font:10pt Times New Roman;margin:0'>G&amp;A:</P>
</TD><TD valign=top style=width:11.46%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>2,486</KBD>&nbsp;</P>
</TD><TD valign=top style='width:9.26%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:11.14%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>2,515</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.06%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:11.14%;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>9,890</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.06%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:11.14%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>9,800</KBD>&nbsp;</P>
</TD><TD valign=top style=width:11.06%><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:12.68%><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>R&amp;D:</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.46%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>141</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:9.26%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.14%;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>111</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.06%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.14%;border-left:1.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>525</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.06%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.14%;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>486</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.06%><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:12.68%><P style='font:10pt Times New Roman;margin:0'>Total OE:</P>
</TD><TD valign=top style='width:11.46%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>2,970</KBD>&nbsp;</P>
</TD><TD valign=top style='width:9.26%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:11.14%;border-top:0.5pt solid #000000;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>2,985</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.06%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:11.14%;border-top:0.5pt solid #000000;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>11,808</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.06%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:11.14%;border-top:0.5pt solid #000000;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>11,840</KBD>&nbsp;</P>
</TD><TD valign=top style=width:11.06%><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Total 2021 OE, with OUS OE converted to USD at the same FX rate as in the prior year&#8217;s same periods of time, were slightly higher in the 4Q and slightly lower for the year as a whole.</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>A division of G&amp;A expenses by location follows. About two-thirds of G&amp;A expenses in all periods above were from the non-cash expense of amortizing IIA related to the Filshie Clip System. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style=width:20.54%><P style='font:10pt Times New Roman;margin:0'>G&amp;A Exp <BR><FONT style='border-bottom:1px solid #000000'>Category</FONT></P>
</TD><TD valign=bottom style=width:11.18%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2021</FONT></P>
</TD><TD valign=bottom style='width:8.14%;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>% of <FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:11.84%;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2020</FONT></P>
</TD><TD valign=bottom style='width:7.48%;border-right:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>% of <FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:11.84%;border-left:1.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2021</FONT></P>
</TD><TD valign=bottom style='width:8.5%;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>% of <FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD><TD valign=bottom style='width:13.22%;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2020</FONT></P>
</TD><TD valign=bottom style=width:7.26%><P align=center style='font:10pt Times New Roman;margin:0'>% of <FONT style='border-bottom:1px solid #000000'>sales</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:20.54%><P style='font:10pt Times New Roman;margin:0'>IIA Amort - UK:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.18%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>536</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:8.14%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:31pt'>4.1</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.84%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>526</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:7.48%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:28pt'>4.4</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.84%;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>2,189</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:8.5%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:33pt'>4.5</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.22%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:55pt'>2,049</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.26%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:27pt'>4.9</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:20.54%><P style='font:10pt Times New Roman;margin:0'>IIA Amort&#8211; CSI:</P>
</TD><TD valign=top style=width:11.18%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>1,105</KBD>&nbsp;</P>
</TD><TD valign=top style='width:8.14%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:31pt'>8.6</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.84%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>1,105</KBD>&nbsp;</P>
</TD><TD valign=top style='width:7.48%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:28pt'>9.2</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.84%;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>4,421</KBD>&nbsp;</P>
</TD><TD valign=top style='width:8.5%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:33pt'>9.0</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.22%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:55pt'>4,421</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.26%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:27pt'>10.5</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:20.54%><P style='font:10pt Times New Roman;margin:0'>UK:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.18%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>146</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:8.14%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.84%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>158</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:7.48%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.84%;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>616</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:8.5%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.22%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:55pt'>608</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.26%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:20.54%><P style='font:10pt Times New Roman;margin:0'>US:</P>
</TD><TD valign=top style=width:11.18%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>545</KBD>&nbsp;</P>
</TD><TD valign=top style='width:8.14%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:11.84%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>573</KBD>&nbsp;</P>
</TD><TD valign=top style='width:7.48%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:11.84%;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>2,208</KBD>&nbsp;</P>
</TD><TD valign=top style='width:8.5%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:13.22%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:55pt'>2,137</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.26%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:20.54%><P style='font:10pt Times New Roman;margin:0'>IRE:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.18%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>86</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:8.14%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.84%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>85</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:7.48%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.84%;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>321</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:8.5%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.22%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:55pt'>284</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.26%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:20.54%><P style='font:10pt Times New Roman;margin:0'>AUS:</P>
</TD><TD valign=top style=width:11.18%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>42</KBD>&nbsp;</P>
</TD><TD valign=top style='width:8.14%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:11.84%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>35</KBD>&nbsp;</P>
</TD><TD valign=top style='width:7.48%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:11.84%;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>178</KBD>&nbsp;</P>
</TD><TD valign=top style='width:8.5%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:13.22%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:55pt'>162</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.26%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:20.54%><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>CAN:</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.18%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>39</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:8.14%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.84%;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>33</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:7.48%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.84%;border-left:1.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>164</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:8.5%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.22%;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:55pt'>139</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.26%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:20.54%><P style='font:10pt Times New Roman;margin:0'>Total G&amp;A:</P>
</TD><TD valign=top style='width:11.18%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:45pt'>2,499</KBD>&nbsp;</P>
</TD><TD valign=top style='width:8.14%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:31pt'>19.3</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.84%;border-top:0.5pt solid #000000;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>2,515</KBD>&nbsp;</P>
</TD><TD valign=top style='width:7.48%;border-right:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:28pt'>21.0</KBD>&nbsp;</P>
</TD><TD valign=top style='width:11.84%;border-top:0.5pt solid #000000;border-left:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:48pt'>10,097</KBD>&nbsp;</P>
</TD><TD valign=top style='width:8.5%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:33pt'>20.6</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.22%;border-top:0.5pt solid #000000;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:55pt'>9,800</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.26%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:27pt'>23.2</KBD>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>The table below identifies &#8220;constant currency&#8221; OUS G&amp;A expenses for 4Q and year 2021 compared to the same periods in 2020:</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style=width:19.96%><P style='font:10pt Times New Roman;margin:0'>G&amp;A Exp <BR><FONT style='border-bottom:1px solid #000000'>Category</FONT></P>
</TD><TD valign=bottom style=width:12.48%><P align=center style='font:10pt Times New Roman;margin:0'>4Q 2021 <BR><FONT style='border-bottom:1px solid #000000'>const FX</FONT></P>
</TD><TD valign=bottom style=width:8.32%><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:12.1%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2020</FONT></P>
</TD><TD valign=bottom style=width:7.64%><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:12.1%><P align=center style='font:10pt Times New Roman;margin:0'>2021 <BR><FONT style='border-bottom:1px solid #000000'>const FX</FONT></P>
</TD><TD valign=bottom style=width:7.64%><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:12.1%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2020</FONT></P>
</TD><TD valign=bottom style=width:7.64%><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:19.96%><P style='font:10pt Times New Roman;margin:0'>IIA Amort- UK:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:12.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:51pt'>524</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:8.32%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>526</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>2,054</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>2,049</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:19.96%><P style='font:10pt Times New Roman;margin:0'>Other&#8211; UK:</P>
</TD><TD valign=top style=width:12.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:51pt'>143</KBD>&nbsp;</P>
</TD><TD valign=top style=width:8.32%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>158</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>578</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>608</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:19.96%><P style='font:10pt Times New Roman;margin:0'>IRE:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:12.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:51pt'>89</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:8.32%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>85</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>312</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>284</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:19.96%><P style='font:10pt Times New Roman;margin:0'>AUS:</P>
</TD><TD valign=top style=width:12.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:51pt'>42</KBD>&nbsp;</P>
</TD><TD valign=top style=width:8.32%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>35</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>164</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:12.1%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>162</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:19.96%><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>CAN:</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:12.48%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:51pt'>38</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:8.32%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:12.1%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>33</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:12.1%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>154</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:12.1%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>139</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:19.96%><P style='font:10pt Times New Roman;margin:0'>Total G&amp;A:</P>
</TD><TD valign=top style='width:12.48%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:51pt'>836</KBD>&nbsp;</P>
</TD><TD valign=top style=width:8.32%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:12.1%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>837</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:12.1%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>3,262</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:12.1%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:50pt'>3,242</KBD>&nbsp;</P>
</TD><TD valign=top style=width:7.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin-top:4pt;margin-bottom:0pt'>Period to period product development (R&amp;D) expenses varied depending on specific project costs. Since almost all R&amp;D is being carried out in the U.S., there was negligible FX rate impact. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>In summary, holding OE nearly constant while substantially increasing revenues with a higher GPM had a huge favorable impact on OI.</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Income Before Tax (EBT)</FONT> </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt'>EBT results from subtracting net non-operating expense (NOE) or adding net non-operating income (NOI) from or to, as applicable, OI. &nbsp;Consolidated 4Q 2021 EBT was $5,181 (40.1% of sales) compared to $4,286 (35.7% of sales) in 4Q 2020. Consolidated 2021 EBT was $19,061 (38.9% of sales) compared to $13,840 (32.8% of sales) in 2020. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>NOE/NOI includes the combination of 1) expenses from loan interest and bank fees; 2) expenses or income from losses or gains from remeasuring the value of EUR cash bank balances in the UK, and GBP cash balances in Ireland, in USD terms; and 3) income from rent of underutilized property, investment income and royalties received from licensing the Company&#8217;s technology. Negative NOE is NOI. &nbsp;Net NOI in 4Q 2021 was $51 compared to $6 NOI in 4Q 2020. Net NOI in 2021 was $181 compared to $132 NOI in 2020. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>EBITDA is a non-US GAAP metric that measures profitability performance without factoring in effects of financing, accounting decisions regarding non-cash expenses, capital expenditures or tax environments. Excluding the noncash effects of depreciation, amortization of intangible assets and stock option expense, 4Q 2021 consolidated EBT excluding the remeasured bank balance currency gain or loss and interest expense (&#8220;adjusted consolidated EBITDA&#8221;) was $7,035 compared to $6,121 in 4Q 2020, an increase of 14.9% in this metric. Adjusted consolidated EBITDA was $26,530 for the year 2021 compared to $21,125 in 2020, an increase of 25.6% in this metric, which exceeded management&#8217;s prior projection. &nbsp;Adjusted consolidated EBITDA for the last six months of 2021 was $14,060, which suggests that management&#8217;s prior projection of $28 million for year 2022 is more likely to be $30 million. &nbsp;</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>UTMD&#8217;s adjusted consolidated EBITDA as a percentage of sales was 54.5% in 4Q 2021 compared to 51.0% in 4Q 2020. &nbsp;UTMD&#8217;s adjusted consolidated EBITDA as a percentage of sales was 54.1% in 2021 compared to 50.1% in 2020. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Achieving substantially higher revenues with an expanded GPM while keeping operating expenses about the same obviously had an extremely positive effect on this key profitability metric. Management believes that this operating performance metric provides meaningful supplemental information to both management and investors and confirms UTMD&#8217;s ongoing excellent financial operating performance, as well as its recovery from 2020. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>UTMD&#8217;s non-US GAAP adjusted consolidated EBITDA is the sum of the elements in the following table, each element of which is a US GAAP number:</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:47.9%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:11.48%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2021</FONT></P>
</TD><TD valign=top style='width:13.54%;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2020</FONT></P>
</TD><TD valign=top style='width:13.54%;border-left:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2021</FONT></P>
</TD><TD valign=top style=width:13.54%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2020</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:47.9%><P style='font:10pt Times New Roman;margin:0'>EBT</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>5,181</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>4,286&#160;</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>19,061</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.54%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>13,840&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:47.9%><P style='font:10pt Times New Roman;margin:0'>Depreciation Expense</P>
</TD><TD valign=top style=width:11.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>153</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>160&#160;</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>636</KBD>&nbsp;</P>
</TD><TD valign=top style=width:13.54%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>655&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:47.9%><P style='font:10pt Times New Roman;margin:0'>Femcare IIA Amortization Expense</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>535</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>526&#160;</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>2,189</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.54%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>2,049&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:47.9%><P style='font:10pt Times New Roman;margin:0'>CSI IIA Amortization Expense</P>
</TD><TD valign=top style=width:11.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>1,105</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>1,105&#160;</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>4,421</KBD>&nbsp;</P>
</TD><TD valign=top style=width:13.54%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>4,421&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:47.9%><P style='font:10pt Times New Roman;margin:0'>Other Non-Cash Amortization Expense</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>8</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>9&#160;</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>35</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.54%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>45&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:47.9%><P style='font:10pt Times New Roman;margin:0'>Stock Option Compensation Expense</P>
</TD><TD valign=top style=width:11.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>43</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>39&#160;</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>166</KBD>&nbsp;</P>
</TD><TD valign=top style=width:13.54%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>160&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:47.9%><P style='font:10pt Times New Roman;margin:0'>Interest Expense</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.48%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>-</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>-&#160;</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>-</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.54%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>-&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:47.9%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Remeasured Foreign Currency Balances</P>
</TD><TD valign=top style='width:11.48%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>10</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>(4)</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>22</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>(45)</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:47.9%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>UTMD non-US GAAP EBITDA:</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.48%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:47pt'>7,035</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>6,121&#160;</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-top:0.5pt solid #000000;border-left:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>26,530</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:56pt'>21,125&#160;</KBD>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Note</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>All UTMD income statement measures from GP through EBT including non-US GAAP adjusted consolidated EBITDA for both 2021 and 2020 time periods were unaffected by the enacted changes in the UK corporate income tax rates.</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Net Income (NI)</FONT> </P>
<P style='font:10pt Times New Roman;margin:0'>NI in 4Q 2021 of $4,131 (32.0% of sales) was 21.1% higher than NI of $3,412 (28.4% of sales) in 4Q 2020. US GAAP NI for the year 2021 of $14,788 (30.1% of sales) was 37.0% higher than the US GAAP NI of $10,798 (25.6% of sales) in 2020. </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>NI per US GAAP in both annual periods was affected by an additional tax provision expense required to be recorded in the quarter in which a tax change is enacted, as a result of an adjustment to UTMD&#8217;s deferred tax liability (DTL). &nbsp;The DTL results from the tax effect of not being able to deduct remaining future amortization expense of Femcare IIA. &nbsp;In 2Q 2020, because the UK reset its corporate tax rate from 17% to 19% going forward, it caused UTMD to have to book an additional $225 in income taxes that represented the additional tax which would be paid in the UK over the remaining six year life of the 2011 Femcare acquisition IIA, based on a 19% rate. In 2Q 2021, because the UK reset its corporate tax rate from 19% to 25% beginning with 2Q 2023, it caused UTMD to have to book an additional $390 in its 2Q 2021 income tax provision that represents the additional tax which will be paid in the UK over the then remaining five year life of the 2011 Femcare acquisition IIA. Excluding the $390 DTL increase in 2Q 2021 and the $225 DTL increase in 2Q 2020, both of which reduced annual NI by those same amounts, year 2021 non-US GAAP NI was $15,178 (30.9% of sales), 37.7% higher than 2020 non-US GAAP NI of $11,023 (26.1% of sales). </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>The average consolidated income tax provisions (as a % of the same period EBT) per US GAAP in 4Q 2021 and 4Q 2020 were 20.3% and 20.4% respectively, and were 22.4% and 22.0% in year 2021 and 2020 respectively. As the income tax provision rates for both 2021 and 2020 years are not directly related to EBT generated in the same periods, UTMD provides the following tax rates excluding the 2Q 2021 $390 tax provision adjustment and the 2Q 2020 $225 income tax provision adjustment: The resulting non-GAAP income tax provision rates were 20.4% for both 2021 and 2020 years. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>The consolidated income tax provision rate varies as the mix in taxable income among U.S. and foreign subsidiaries with differing income tax rates differs from period to period. UTMD has consistently paid millions of dollars in income taxes annually. The basic 2021 corporate income tax rates in each of the sovereignties were the same as in the prior year. </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Earnings per share (EPS)</FONT>.</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Diluted EPS in 4Q 2021 were $1.127 compared to $0.934 in 4Q 2020, a 20.6% increase. &nbsp;US GAAP diluted EPS in year 2021 were $4.041 compared to $2.941 in 2020, a 37.4% increase. &nbsp;Excluding the &#8220;one-time&#8221; income tax provision increases due to the DTL adjustments, non-US GAAP diluted EPS in 2021 were $4.147 compared to $3.002 in 2020, a 38.2% increase, which is more indicative of normal operating results. The increases in EPS were substantial as a result of the 2021 improvement in revenues and GPM while holding OE about the same as in 2020. Diluted shares were 3,667,199 in 4Q 2021 compared to 3,652,084 in 4Q 2020. &nbsp;The higher diluted shares in 4Q 2021 were the result of employee options exercised. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>The number of shares used for calculating 4Q 2021 and year 2021 EPS were higher than the December 31, 2021 outstanding shares balance because of a time-weighted calculation of average outstanding shares plus dilution from unexercised employee and director options. Outstanding shares at the end of calendar year 2021 were 3,654,737 compared to 3,643,035 at the end of 2020. The difference was due to 13,711 shares in employee option exercises during 2021, less 2,009 shares swapped to pay the exercise price. For comparison, outstanding shares were 3,648,984 at the end of 3Q 2021. The total number of outstanding unexercised employee and outside director options at December 31, 2021 was 51,858 at an average exercise price of $69.24, including shares awarded but not yet vested. This compares to 69,036 unexercised option shares at the end of 2020 at an average exercise price of $67.23/ share, including shares awarded but not vested. </P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>The number of shares added as a dilution factor for 4Q 2021 was 15,132 compared to 11,091 in 4Q 2020. The number of shares added as a dilution factor for the year 2021 was 12,606 compared to 14,018 in 2020. In March 2020, 26,300 option shares were awarded to 48 employees at an exercise price of $77.05 per share. No options were awarded in 2021. UTMD paid $8,349 ($2.285/share) in dividends to stockholders in 4Q 2021 compared to $1,018 ($0.280/ share) paid in 4Q 2020. The dividends paid in 4Q 2021 included a regular $0.285/share dividend declared in September after 3Q 2021, and a special $2.00/ share dividend declared in November and paid in December in lieu of a regular dividend that otherwise would have been paid in January 2022. Without having been able to repurchase its shares in 2021, the special dividend helped the Company continue to achieve its continuing capital allocation objective of returning value to stockholders. UTMD paid $11,465 ($3.14/share) in dividends to stockholders in 2021 compared to $4,116 ($1.12/ share) in dividends and $6,976 in share repurchases in 2020. &nbsp;&nbsp;&nbsp;&nbsp;</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>In March 2020, UTMD repurchased 80,000 of its shares in the open market at $80.32/ share. In September 2020, UTMD repurchased 7,000 shares at $78.67/ share. &nbsp;No shares were repurchased in 2021. The Company retains the strong desire and financial ability for repurchasing its shares at a price it believes is attractive for remaining stockholders. UTMD&#8217;s closing share price at the end of 2021 was $100.00, up 7.7% from the closing price of $92.84 at the end of 3Q 2021, and up 18.6% from the closing price of $84.30 at the end of 2020. &nbsp;The average enterprise value of publicly-traded medical device companies is published by financial firms to be currently north of 20 times EBITDA. At only 15 times projected 2022 EBITDA plus $61 million in cash which existed at the end of 2021 with no debt, UTMD&#8217;s projected enterprise value would be $511 million or about $139.00/share with 3.68 million diluted shares. </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Balance Sheet</FONT>.</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>At December 31, 2021 compared to the end of 2020, UTMD&#8217;s cash and investments increased $9.4 million to $61.0 million as a result of operating EBITDA minus the $11.5 million in cash dividends paid to stockholders, and a $0.7 million increase in non-cash and dividend working capital as a result of higher sales and production activity. At December 31, 2021, Net Intangible Assets decreased to 27.2% of total consolidated assets from 34.1% on December 31, 2020. &nbsp;</P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Financial ratios as of December 30, 2021 which may be of interest to stockholders follow:</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:18pt'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:-18pt'>1)</KBD>Current Ratio = 20.3&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:18pt'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:-18pt'>2)</KBD>Days in Trade Receivables (based on 4Q 2021 sales activity) = 35.8&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:18pt'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:-18pt'>3)</KBD>Average Inventory Turns (based on 4Q 2021 CGS) = 3.0&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:18pt'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:-18pt'>4)</KBD>2021 ROE (before dividends) = 14%&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Investors are cautioned that this press release contains forward looking statements and that actual events may differ from those projected. &nbsp;Risk factors that could cause results to differ materially from those projected include global economic conditions, market acceptance of products, regulatory approvals of products, regulatory intervention in current operations, government intervention in healthcare in general, tax reforms, the Company&#8217;s ability to efficiently manufacture, market and sell products, cybersecurity and foreign currency exchange rates, among other factors that have been and will be outlined in UTMD&#8217;s public disclosure filings with the SEC. &nbsp;UTMD&#8217;s 2021 SEC Form 10-K will be filed on or before March 31, 2022, and can be accessed on <FONT style='color:#0000FF;border-bottom:1px solid #0000FF'><B><I>www.utahmed.com</I></B></FONT>.</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over one hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. &nbsp;For more information about Utah Medical Products, Inc., visit UTMD&#8217;s website at<B><I> </I></B><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'><B><I>www.utahmed.com</I></B></FONT>.</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><B>Utah Medical Products, Inc.</B></P>
<P style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>INCOME STATEMENT, Fourth Quarter (three months ended December 31)</P>
<P style='font:10pt Times New Roman;margin:0'>(in thousands except earnings per share):</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:39.42%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.14%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2021</FONT></P>
</TD><TD valign=top style=width:15.14%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2020</FONT></P>
</TD><TD valign=top style=width:15.14%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Percent Change</FONT></P>
</TD><TD valign=top style=width:15.14%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>4Q 2019</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:39.42%><P style='font:10pt Times New Roman;margin:0'>Net Sales</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>12,914</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>12,010</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>7.5%</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>11,831</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:39.42%><P style='font:10pt Times New Roman;margin:0'>Gross Profit</P>
</TD><TD valign=top style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>8,112</KBD>&nbsp;</P>
</TD><TD valign=top style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>7,265</KBD>&nbsp;</P>
</TD><TD valign=top style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>11.7%</KBD>&nbsp;</P>
</TD><TD valign=top style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>7,814</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:39.42%><P style='font:10pt Times New Roman;margin:0'>Operating Income</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>5,129</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>4,280</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>19.8%</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>4,679</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:39.42%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Income Before Tax</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>5,181</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>4,286</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>20.9%</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>4,735</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:39.42%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>Net Income before DTL adjust</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>4,131</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>3,412</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>21.1%</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>3,777</I></KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:39.42%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Net Income (US GAAP)</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>4,131</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>3,412</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>21.1%</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>4,359</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:39.42%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>Diluted EPS before DTL adjust</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'><I>$</I></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>1.127</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'><I>$</I></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>.934</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>20.6%</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'><I>$</I></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>1.165</I></KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:39.42%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Diluted EPS (US GAAP)</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>1.127</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>.934</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>20.6%</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>1.010</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:39.42%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Shares Outstanding (diluted)</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>3,667</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>3,652</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>3,740</KBD>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>INCOME STATEMENT, Twelve Months (Calendar Year ended December 31)</P>
<P style='font:10pt Times New Roman;margin:0'>(in thousands except earnings per share): </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:39.44%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.14%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2021</FONT></P>
</TD><TD valign=top style=width:15.14%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2020</FONT></P>
</TD><TD valign=top style=width:15.14%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Percent Change</FONT></P>
</TD><TD valign=top style=width:15.14%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2019</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:39.44%><P style='font:10pt Times New Roman;margin:0'>Net Sales</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>49,054</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>42,178</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>16.3%</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>46,904</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:39.44%><P style='font:10pt Times New Roman;margin:0'>Gross Profit</P>
</TD><TD valign=top style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>30,917</KBD>&nbsp;</P>
</TD><TD valign=top style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>25,548</KBD>&nbsp;</P>
</TD><TD valign=top style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>21.0%</KBD>&nbsp;</P>
</TD><TD valign=top style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>29,466</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:39.44%><P style='font:10pt Times New Roman;margin:0'>Operating Income</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>18,880</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>13,708</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>37.7%</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.14%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>17,633</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:39.44%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Income Before Tax</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>19,061</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>13,840</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>37.7%</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>17,884</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:39.44%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>Net Income before DTL adjust</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>15,178</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>11,023</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>37.7%</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>14,145</I></KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:39.44%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Net Income (US GAAP)</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>14,788</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>10,798</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>37.0%</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>14,727</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:39.44%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>Diluted EPS before DTL adjust</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'><I>$</I></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>4.147</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'><I>$</I></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>3.002</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>38.2%</I></KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'><I>$</I></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'><I>3.784</I></KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:39.44%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Diluted EPS (US GAAP)</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>4.041</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>2.941</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>37.4%</KBD>&nbsp;</P>
</TD><TD valign=top style='width:15.14%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>3.939</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:39.44%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Shares Outstanding (diluted)</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>3,660</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>3,672</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.14%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:64pt'>3,739</KBD>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>BALANCE SHEET </P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>(in thousands)</P>
</TD><TD valign=bottom style=width:16.66%><P align=center style='font:10pt Times New Roman;margin:0'>(audited)<BR><FONT style='border-bottom:1px solid #000000'>DEC 31, 2021</FONT></P>
</TD><TD valign=bottom style=width:16.66%><P align=center style='font:10pt Times New Roman;margin:0'>(unaudited)<BR><FONT style='border-bottom:1px solid #000000'>SEP 30, 2021</FONT></P>
</TD><TD valign=bottom style=width:16.64%><P align=center style='font:10pt Times New Roman;margin:0'>(audited)<BR><FONT style='border-bottom:1px solid #000000'>DEC 31, 2020</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Assets</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.64%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0;margin-left:9pt'>Cash &amp; Investments</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>60,974</KBD>&nbsp;</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>64,321</KBD>&nbsp;</P>
</TD><TD valign=top style=width:16.64%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>51,590</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0;margin-left:9pt'>Accounts &amp; Other Receivables, Net</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>5,132</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>4,853</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.64%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>4,104</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0;margin-left:9pt'>Inventories</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>6,596</KBD>&nbsp;</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>6,299</KBD>&nbsp;</P>
</TD><TD valign=top style=width:16.64%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>6,222</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0;margin-left:9pt'>Other Current Assets</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.66%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>456</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.66%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>373</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.64%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>346</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'>Total Current Assets</P>
</TD><TD valign=top style='width:16.66%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>73,158</KBD>&nbsp;</P>
</TD><TD valign=top style='width:16.66%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>75,846</KBD>&nbsp;</P>
</TD><TD valign=top style='width:16.64%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>62,262</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>Property &amp; Equipment, Net</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>10,992</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>10,932</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.64%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>11,326</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>Intangible Assets, Net</P>
</TD><TD valign=top style='width:16.66%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>31,412</KBD>&nbsp;</P>
</TD><TD valign=top style='width:16.66%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>32,974</KBD>&nbsp;</P>
</TD><TD valign=top style='width:16.64%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>38,157</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0;margin-left:27pt'>Total Assets</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.66%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>115,561</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.66%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>119,752</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.64%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>111,745</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:16.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Liabilities &amp; Stockholders&#8217; Equity</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>Accounts Payable</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>761</KBD>&nbsp;</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>1,026</KBD>&nbsp;</P>
</TD><TD valign=top style=width:16.64%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>788</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>REPAT Tax Payable</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>237</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>237</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.64%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>79</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>Other Accrued Liabilities</P>
</TD><TD valign=top style='width:16.66%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>2,602</KBD>&nbsp;</P>
</TD><TD valign=top style='width:16.66%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>3,752</KBD>&nbsp;</P>
</TD><TD valign=top style='width:16.64%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>2,924</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0;margin-left:9pt'>Total Current Liabilities</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.66%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>3,600</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.66%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>5,015</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.64%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>3,791</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>Deferred Tax Liability &#8211;&nbsp;Intangible Assets</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>2,105</KBD>&nbsp;</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>2,196</KBD>&nbsp;</P>
</TD><TD valign=top style=width:16.64%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>2,151</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>Long Term Lease Liability</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>331</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>343</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.64%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>335</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>Long Term REPAT Tax Payable</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>1,810</KBD>&nbsp;</P>
</TD><TD valign=top style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>1,810</KBD>&nbsp;</P>
</TD><TD valign=top style=width:16.64%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>1,995</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>Deferred Revenue and Income Taxes</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>577</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.66%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>408</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.64%><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>651</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:50.04%><P style='font:10pt Times New Roman;margin:0'>Stockholders&#8217; Equity</P>
</TD><TD valign=top style='width:16.66%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>107,138</KBD>&nbsp;</P>
</TD><TD valign=top style='width:16.66%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>109,980</KBD>&nbsp;</P>
</TD><TD valign=top style='width:16.64%;border-bottom:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>102,822</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.04%><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'>Total Liabilities &amp; Stockholders&#8217; Equity</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.66%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>115,561</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.66%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>119,752</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.64%;border-top:0.75pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:71pt'>111,745</KBD>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'></DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>utmd-20220201_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2022 [PPXK5GW761L0VFNE7HJL]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://utahmed.com/20220201"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
	<link:roleRef roleURI="http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="utmd-20220201.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>utmd-20220201_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2022 [PPXK5GW761L0VFNE7HJL]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://utahmed.com/20220201"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityVoluntaryFilers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Voluntary filer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityVoluntaryFilers' xlink:to='lab_dei_EntityVoluntaryFilers'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFilerCategory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Filer Category</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentFlag' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Flag</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber' xlink:label='dei_LocalPhoneNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_LocalPhoneNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Local Phone Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_LocalPhoneNumber' xlink:to='lab_dei_LocalPhoneNumber'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown' xlink:label='dei_EntityAddressCityOrTown'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressCityOrTown' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, City or Town</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressCityOrTown' xlink:to='lab_dei_EntityAddressCityOrTown'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber' xlink:label='dei_EntityFileNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFileNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity File Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFileNumber' xlink:to='lab_dei_EntityFileNumber'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod' xlink:label='dei_EntityExTransitionPeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityExTransitionPeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Ex Transition Period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityExTransitionPeriod' xlink:to='lab_dei_EntityExTransitionPeriod'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent' xlink:label='dei_EntityInteractiveDataCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityInteractiveDataCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interactive Data Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityInteractiveDataCurrent' xlink:to='lab_dei_EntityInteractiveDataCurrent'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SEC Form</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TextBlockAbstract' xlink:to='lab_us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications' xlink:label='dei_WrittenCommunications'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_WrittenCommunications' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Written Communications</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_WrittenCommunications' xlink:to='lab_dei_WrittenCommunications'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness' xlink:label='dei_EntitySmallBusiness'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntitySmallBusiness' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Small Business</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntitySmallBusiness' xlink:to='lab_dei_EntitySmallBusiness'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode' xlink:label='dei_CityAreaCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CityAreaCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>City Area Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CityAreaCode' xlink:to='lab_dei_CityAreaCode'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CurrentFiscalYearEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fiscal Year End</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CurrentFiscalYearEndDate' xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer' xlink:label='dei_PreCommencementTenderOffer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_PreCommencementTenderOffer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Pre-commencement Tender Offer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_PreCommencementTenderOffer' xlink:to='lab_dei_PreCommencementTenderOffer'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode' xlink:label='dei_EntityIncorporationStateCountryCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityIncorporationStateCountryCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Incorporation, State or Country Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityIncorporationStateCountryCode' xlink:to='lab_dei_EntityIncorporationStateCountryCode'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany' xlink:label='dei_EntityShellCompany'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityShellCompany' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shell Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityShellCompany' xlink:to='lab_dei_EntityShellCompany'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_TradingSymbol' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading Symbol</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_TradingSymbol' xlink:to='lab_dei_TradingSymbol'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial' xlink:label='dei_SolicitingMaterial'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_SolicitingMaterial' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Soliciting Material</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_SolicitingMaterial' xlink:to='lab_dei_SolicitingMaterial'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of common stock shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCommonStockSharesOutstanding' xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCentralIndexKey' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Registrant CIK</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCentralIndexKey' xlink:to='lab_dei_EntityCentralIndexKey'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Well-known Seasoned Issuer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityWellKnownSeasonedIssuer' xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityRegistrantName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Registrant Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince' xlink:label='dei_EntityAddressStateOrProvince'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressStateOrProvince' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, State or Province</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressStateOrProvince' xlink:to='lab_dei_EntityAddressStateOrProvince'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany' xlink:label='dei_EntityEmergingGrowthCompany'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityEmergingGrowthCompany' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Emerging Growth Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityEmergingGrowthCompany' xlink:to='lab_dei_EntityEmergingGrowthCompany'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode' xlink:label='dei_EntityAddressPostalZipCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressPostalZipCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, Postal Zip Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressPostalZipCode' xlink:to='lab_dei_EntityAddressPostalZipCode'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCurrentReportingStatus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current with reporting</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCurrentReportingStatus' xlink:to='lab_dei_EntityCurrentReportingStatus'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityPublicFloat' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Public Float</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityPublicFloat' xlink:to='lab_dei_EntityPublicFloat'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName' xlink:label='dei_SecurityExchangeName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_SecurityExchangeName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading Exchange</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_SecurityExchangeName' xlink:to='lab_dei_SecurityExchangeName'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1' xlink:label='dei_EntityAddressAddressLine1'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressAddressLine1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, Address Line One</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressAddressLine1' xlink:to='lab_dei_EntityAddressAddressLine1'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription' xlink:label='dei_AmendmentDescription'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentDescription' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Description</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentDescription' xlink:to='lab_dei_AmendmentDescription'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentPeriodEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Period End date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentPeriodEndDate' xlink:to='lab_dei_DocumentPeriodEndDate'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer' xlink:label='dei_PreCommencementIssuerTenderOffer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_PreCommencementIssuerTenderOffer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Pre-commencement Issuer Tender Offer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_PreCommencementIssuerTenderOffer' xlink:to='lab_dei_PreCommencementIssuerTenderOffer'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber' xlink:label='dei_EntityTaxIdentificationNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityTaxIdentificationNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Tax Identification Number (TIN)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityTaxIdentificationNumber' xlink:to='lab_dei_EntityTaxIdentificationNumber'/>
	</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>utmd-20220201_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2022 [PPXK5GW761L0VFNE7HJL]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://utahmed.com/20220201"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="utmd-20220201.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCentralIndexKey' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_CurrentFiscalYearEndDate' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityRegistrantName' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_DocumentType' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_DocumentPeriodEndDate' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_TradingSymbol' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName' xlink:label='dei_SecurityExchangeName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_SecurityExchangeName' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber' xlink:label='dei_EntityTaxIdentificationNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityTaxIdentificationNumber' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCommonStockSharesOutstanding' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityPublicFloat' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityFilerCategory' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCurrentReportingStatus' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent' xlink:label='dei_EntityInteractiveDataCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityInteractiveDataCurrent' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityVoluntaryFilers' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityWellKnownSeasonedIssuer' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany' xlink:label='dei_EntityShellCompany'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityShellCompany' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness' xlink:label='dei_EntitySmallBusiness'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntitySmallBusiness' use='optional' order='17.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany' xlink:label='dei_EntityEmergingGrowthCompany'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityEmergingGrowthCompany' use='optional' order='18.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod' xlink:label='dei_EntityExTransitionPeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityExTransitionPeriod' use='optional' order='19.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription' xlink:label='dei_AmendmentDescription'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_AmendmentDescription' use='optional' order='20.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode' xlink:label='dei_EntityIncorporationStateCountryCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityIncorporationStateCountryCode' use='optional' order='21.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber' xlink:label='dei_EntityFileNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityFileNumber' use='optional' order='22.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1' xlink:label='dei_EntityAddressAddressLine1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressAddressLine1' use='optional' order='23.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown' xlink:label='dei_EntityAddressCityOrTown'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressCityOrTown' use='optional' order='24.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince' xlink:label='dei_EntityAddressStateOrProvince'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressStateOrProvince' use='optional' order='25.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode' xlink:label='dei_EntityAddressPostalZipCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressPostalZipCode' use='optional' order='26.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode' xlink:label='dei_CityAreaCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_CityAreaCode' use='optional' order='27.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber' xlink:label='dei_LocalPhoneNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_LocalPhoneNumber' use='optional' order='28.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications' xlink:label='dei_WrittenCommunications'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_WrittenCommunications' use='optional' order='29.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial' xlink:label='dei_SolicitingMaterial'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_SolicitingMaterial' use='optional' order='30.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer' xlink:label='dei_PreCommencementTenderOffer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_PreCommencementTenderOffer' use='optional' order='31.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer' xlink:label='dei_PreCommencementIssuerTenderOffer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_PreCommencementIssuerTenderOffer' use='optional' order='32.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_AmendmentFlag' use='optional' order='33.0'/>
	</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>utmd-20220201.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2022 [PPXK5GW761L0VFNE7HJL]. www.edgarsuite.com -->
<schema xmlns='http://www.w3.org/2001/XMLSchema' xmlns:us-gaap='http://fasb.org/us-gaap/2020-01-31' xmlns:fil='http://utahmed.com/20220201' xmlns:dei='http://xbrl.sec.gov/dei/2020-01-31' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xbrldt='http://xbrl.org/2005/xbrldt' targetNamespace='http://utahmed.com/20220201' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xbrli='http://www.xbrl.org/2003/instance' elementFormDefault='qualified' attributeFormDefault='unqualified'>
	<annotation>
		<appinfo>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20220201_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20220201_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20220201_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:roleType roleURI="http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
				<link:definition>000010 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
		</appinfo>
	</annotation>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import namespace='http://fasb.org/us-gaap/2020-01-31' schemaLocation='http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd' />
	<import namespace='http://xbrl.sec.gov/dei/2020-01-31' schemaLocation='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd' />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140662125349608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Registrant CIK</a></td>
<td class="text">0000706698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">UTAH MEDICAL PRODUCTS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">SEC Form</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Period End date</a></td>
<td class="text">Feb.  01,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Tax Identification Number (TIN)</a></td>
<td class="text">87-0342734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-12575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7043 South 300 West<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Midvale<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">566-1200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>utmd-20220201_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="utmd-20220201.xsd" xlink:type="simple"/>
    <context id="D220201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000706698</identifier>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-01</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="D220201" id="fact1">0000706698</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="D220201" id="fact2">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="D220201">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="D220201">2022-02-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="D220201">UTAH MEDICAL PRODUCTS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="D220201">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="D220201">000-12575</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="D220201">87-0342734</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="D220201">7043 South 300 West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="D220201">Midvale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="D220201">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="D220201">84047</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="D220201">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="D220201">566-1200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="D220201">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="D220201">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="D220201">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="D220201">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="D220201">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M!;N=BZB9)IUFBM!U2[HN*G9;,+WD<DE^AT"[(B-5K*G\J*/"A194&(8 795
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ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
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M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ C95!5)E<G",0!@  G"<  !,
M             ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" "-E4%4"H%!Z<P#  !*#@  &               @($-"   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ C95!5)^@&_"Q @  X@P   T
M             ( !#PP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "-E4%4
MEXJ[',     3 @  "P              @ 'K#@  7W)E;',O+G)E;'-02P$"
M% ,4    " "-E4%4'#AEZC\!   \ @  #P              @ '4#P  >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ C95!5"0>FZ*M    ^ $  !H
M         ( !0!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ C95!5&60>9(9 0  SP,  !,              ( !)1(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ;Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="utmd-20220201.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="utmd-20220201.htm">utmd-20220201.htm</File>
    <File>utah_ex99z1.htm</File>
    <File>utmd-20220201.xsd</File>
    <File>utmd-20220201_def.xml</File>
    <File>utmd-20220201_lab.xml</File>
    <File>utmd-20220201_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="19">http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "utmd-20220201.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "utmd-20220201_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "utmd-20220201.htm"
     ]
    },
    "labelLink": {
     "local": [
      "utmd-20220201_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "utmd-20220201_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "utmd-20220201.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 34,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fil",
   "nsuri": "http://utahmed.com/20220201",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "utmd-20220201.htm",
      "contextRef": "D220201",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010 - Document - Document and Entity Information",
     "role": "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "utmd-20220201.htm",
      "contextRef": "D220201",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Fiscal Year End"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Period End date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "SEC Form"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Registrant CIK"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Number of common stock shares outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Current with reporting"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Tax Identification Number (TIN)"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Voluntary filer"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Trading Exchange"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20220201/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Details"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r4": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r5": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001096906-22-000245-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001096906-22-000245-xbrl.zip
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M6U% CV<AS2(W"B+8Q,">P/(0JUH&JQG8*_0>0AMF)03$BPD0U#Z)I)A*  0
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MG#GF$%C>.8$5\7#44<Q&-TL;Z>-YB"H,OL3/%\B+"-)K*HV0.0LH+8]:8)K
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ML($!_P$"/F079P'OQVN1B2FH.2QG B/"3][XZ97G34:>+SZP$Y^/O0<1Y/N
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M5IY5Y-!$JI@TC %"^X?('9;2(Y-8C!W9\%W/%<G!*K"F:U&6*::NDU4R9T,
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MF_ARJ9//7ZY.F><S:S"8_Z0M]@X/7I^*D?'^+4^AJ[<F$\?N(R851" 3N[H
M8D'XT1U5<9(HK@^I^:BIZ!V=G30TD/1X;P?=Q'&:2_<]:BA&I\5.S*;:SCX#
M#"*3)%66FR0_@]Y5M!9,87;4[L(I=!,O<H.'#+4S-8>80.QET;]+H!P@_0J
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M4H&\8H1X**$T(0($M:$9U?,]:P!TXXHFR8!J$*CDY*&^^#P2'Z0OA]H"9T]
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MBR07P5'&-JT,88$K/![TCC*Q-*AT.<\0J6C@45\$["@3B,ROU9\.^PI&PNA
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M?21GC>-FO79*+MKGQU?USB5,U:J;Q" GL!IDW_A$+AMUTN7 B=YA-AGXT^&
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M(,0>Z45BJ/HH%"$F%E02CW5YD)QC3*))JW#+0>?9^>8]LC,Y&ZUCRDEWKL]
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MD8O]^R/QUQ@&"/!4_.!D=\;8_*C=%F.68^KN$SIM<Q?OVJGA[LZK5Y'MT3+
M.?O%N]2ZV_[Y]7IHSY '+>P'3.04C0OP41!=OB9VE-0&#H'20OQDI6:6N&1U
M#ZQWW?UEX#R&.<'NVDO(X,Q#CJA!6]2L<]#I/EH*J.=5H# BJ4'W\/"P'7V;
M,>9@#EM;9['?M^,O\\:X))9U54]W7AU3XJ([- &1PR.VFJ.3W0![<Q?M)M=F
M%$WD:"ZE;3&^[2,F2G@H2MC]($KXFE^ZAF/D[@)A\>VNKPSH<(T1#VC7&-84
M,N040XLN/S>\S*!MA3A %!/GPG]9K$]&;S?H(8/TV0J0C]]6X",^&:,7A9P9
MN;5@"8/NRX)]'+FM8&^>/QGDQT6!QFN.^/F:?\K%BY8,^0YRTH@%2,D,&/F(
M9EB.FP(3.PO9<L4J0V@K6X.60 S2"3A ]OZ4/+0=A,6"T!$?Q&K:L3K=9"5Y
MS2_]NO 99JOOQ U]+NK5)7:Y7%+<*)^3EMJNG0E1V.:"I"@@(;71$S3^SZ]*
MSU&-6A4U$G@ML;YS:-&8(-_Z-FR=KB'!1& >MQ^]/PGWC-J 4 ?1I,?)1@^I
MG5[@'ROB22S:-N%+UYQ9:6C1\ DE7ED14[>DJC;M[0DB\MCC,I\2NE+*(6^E
M+P:I5QTI1( @131."=)\BSI0E[DQ%9QY?,KB?]BE"Z<2_O/?ZS O]:3#^1H0
M"$2#.)=FFF5;7=3&>!:W*^Y@1GQT$WIC1"54%TQTV%;YTR$\P@01*(A1#2)=
ME7"6]](*-SS1GSD.IRSH\8^W=$06OG*R+UKJ3_A*[SIZB*%!@KT'!#KG' A\
M@Y1148'B,E!.P!8: N4443"IIQ6H;XI()"% S9LB5 G+&X'M3Q$7RQ&%?H#%
MME9\_ZN4@,147PIJ_UJ26()'6!#C&B<*=>I%<534OF&1]'V&*+09?D#GD,%>
M2"EO9)1"49CKBZ4\#AW!9)"!@ 8)MG&B*2]!43@;<-&8>,Z)'8J.=\1Q)6+)
M?:TC#ID?'3$,+WK@DE#/(/)E*6;)5M9R4W)3;B<P&$?1A8$UA7 >$XQ<%J17
MGC*=7/XU0DOV.\>_/QL'3$CN"5MJNY=R7^E91P3GB$'L!H9HH#+55 R;5;FQ
M7_D?%#.&_![QO-#'\=,RV8ZCW$YG$BCUK".$!!CDD0W1167FV4FBNN@-]Q%#
M#[KN[V& ?7ZKHVP?\E;Z78/4J];Z( !!BFB0$DKR+78&ZC(WI@)Q=WM&$>P1
M1]80Y+[6X5WF1X?P:)-!  *!:!#ALD2S3"LKVAS%<8-YB0,;NG\A2"]\AS>>
M4KI5IEK45_C7>^ @0(% !1S6)!U49)W3Q"9E;TP? XK$^H-X.E&_*AZ>TMO)
M1+KU5&*LHY'J&'14PM$M.P,/8GP0.3!(,]55R*IF0RH:WXBP"9T3&K4N0\95
MVR.AS^A*L:)L,JJ.;8D-HJIAAS/G9P]$GL3>=^+-M,7I&<61[5MLREG3/>L,
MN:XXV A]];/RG%$-':O$IU;#*O!  FB<0F392MI558D;XW]$H3@3.UQY8^)*
MJ,]_K\.ZU),.X0D@B!$-8ER::99L=5$;XWE(7&QCQKU^Y=,,Q5!&ML1(AW&U
M3ZW?\S4J2&$-XEZ=<U8 %85N>+87/8Y8;XA]/YQ!3N)MR,299:%)Y>Q?.DA_
M-=@D)AW5Q \= 9D ._($ N$*!)$O0!Z=&:2ES2M37$DVIJMIK?$^FD*WSSOI
MY152-Q=/[6I0E-RSCHCNT!2+C69^O]/K7YFG%'G&$G&4%+MA/?S@#<Z53Q;^
M$,& ^,CI!T%8<B1#9:^OCXI(M';3.;1U+[!!"@YB=.,T4U&%HG8V(:1A#3W^
M&MY 3WU'_,1,7S%ROS5-* +2.'7(,RZ*HJ34VSG]%]T\W](!)0_8+]!8:5[;
M.4!%''4>!ESOB*1.C%-->2V4QP++2&GZ@)B'Z)1W1E\H6;!9U4:(W+J&8V)E
M46A)* $&,;*QFR2E!9"<%ZOD83N3SX#PSMK]&\]+-VBEQK5-/-(8ZIQV8@>
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MI#?,V9$?NT)^+Y"9\X]6\9A3"^KR]HHCWC!C1_O:%=H1#A.A!Z_^,IPA-L7
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M_B_F:O]?4$L! A0#%     @ C95!5$>;UV:M0@  LVT"  \
M ( !     '5T86A?97@Y.7HQ+FAT;5!+ 0(4 Q0    ( (V5050R]PHS*0X
M "1>   1              "  =I"  !U=&UD+3(P,C(P,C Q+FAT;5!+ 0(4
M Q0    ( (V5052@,N1_W0,  /&"   1              "  3)1  !U=&UD
M+3(P,C(P,C Q+GAS9%!+ 0(4 Q0    ( (V5052-"+=E& (  "8'   5
M          "  3Y5  !U=&UD+3(P,C(P,C Q7V1E9BYX;6Q02P$"% ,4
M" "-E4%4+%5XO3$(  "=3P  %0              @ &)5P  =71M9"TR,#(R
M,#(P,5]L86(N>&UL4$L! A0#%     @ C95!5+N$$C2M!0  $34  !4
M         ( ![5\  '5T;60M,C R,C R,#%?<')E+GAM;%!+!08     !@ &
+ (0!  #-90     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
